These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 27734745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
    Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.
    Am J Drug Alcohol Abuse; 2012 May; 38(3):187-99. PubMed ID: 22404717
    [Abstract] [Full Text] [Related]

  • 3. Medications for management of opioid use disorder.
    Koehl JL, Zimmerman DE, Bridgeman PJ.
    Am J Health Syst Pharm; 2019 Jul 18; 76(15):1097-1103. PubMed ID: 31361869
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Buprenorphine for managing opioid withdrawal.
    Gowing L, Ali R, White JM, Mbewe D.
    Cochrane Database Syst Rev; 2017 Feb 21; 2(2):CD002025. PubMed ID: 28220474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug 27; 60(1554):137-141. PubMed ID: 30133420
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
    Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.
    Curr Drug Abuse Rev; 2012 Mar 27; 5(1):52-63. PubMed ID: 22280332
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE, Klie KA.
    Semin Perinatol; 2019 Apr 27; 43(3):141-148. PubMed ID: 30755340
    [Abstract] [Full Text] [Related]

  • 12. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.
    Pharmacotherapy; 2017 Jul 27; 37(7):824-839. PubMed ID: 28543191
    [Abstract] [Full Text] [Related]

  • 13. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.
    Arch Gen Psychiatry; 2005 Oct 27; 62(10):1157-64. PubMed ID: 16203961
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE, Tompkins DA, Bigelow GE, Strain EC.
    JAMA Psychiatry; 2017 Sep 01; 74(9):885-893. PubMed ID: 28700791
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder.
    Bello JK, Xu KY, Salas J, Bedrick BS, Grucza RA.
    J Gen Intern Med; 2024 Jun 01; 39(8):1342-1348. PubMed ID: 38424347
    [Abstract] [Full Text] [Related]

  • 16. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T, Knudsen HK, Brown R, Jacobson N, Horst J, Van Etten M, Kim JS, Haram E, Collier E, Starr S, Toy A, Madden L.
    Implement Sci; 2017 Nov 15; 12(1):135. PubMed ID: 29141653
    [Abstract] [Full Text] [Related]

  • 17. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 18. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
    Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M.
    Expert Opin Pharmacother; 2017 Dec 01; 18(18):1987-1999. PubMed ID: 29183228
    [Abstract] [Full Text] [Related]

  • 19. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP, Presnall N, Stringfellow E, Wood C, Horn P, Duello A, Green L, Rudder T.
    Am J Drug Alcohol Abuse; 2019 Dec 01; 45(4):333-340. PubMed ID: 31084515
    [Abstract] [Full Text] [Related]

  • 20. Maintenance medication for opiate addiction: the foundation of recovery.
    Bart G.
    J Addict Dis; 2012 Dec 01; 31(3):207-25. PubMed ID: 22873183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.